Normal tissue radioprotection by amifostine via Warburg-type effects - Wikidata - wikimedia - TriplyDB

Normal tissue radioprotection by amifostine via Warburg-type effects

Normal tissue radioprotection by amifostine via Warburg-type effects

http://www.wikidata.org/entity/Q28830846

about

Metabolic Pathways of the Warburg Effect in Health and Disease: Perspectives of Choice, Chain or Chance.

P2860

Q47392278-CC29E024-E6B9-4CE6-8902-235009F7524F

P2860

Normal tissue radioprotection by amifostine via Warburg-type effects

http://www.wikidata.org/entity/Q28830846

description

2016 nî lūn-bûn

@nan

2016 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2016 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

name

Normal tissue radioprotection by amifostine via Warburg-type effects

@ast

Normal tissue radioprotection by amifostine via Warburg-type effects

@en

type

label

Normal tissue radioprotection by amifostine via Warburg-type effects

@ast

Normal tissue radioprotection by amifostine via Warburg-type effects

@en

prefLabel

Normal tissue radioprotection by amifostine via Warburg-type effects

@ast

Normal tissue radioprotection by amifostine via Warburg-type effects

@en

P1433

Q28830846-B2546406-B221-43AB-A4A5-0FC7FCD7F524

P1476

Q28830846-5D1CB81C-3D3C-4FB6-9899-514B4E964871

P2093

Q28830846-2B339862-C938-4F6E-89CD-E3870AF735E3

Q28830846-45E05B3D-B28E-4B39-A14C-D29C5998EC27

Q28830846-541A90C0-2638-4AF9-B962-27E507D45EAF

Q28830846-6C12065D-D16D-445E-93E8-9EA4BF6ACA8B

Q28830846-72A4C867-A036-4CAF-8A36-2458D0CF53FA

Q28830846-8A7C564D-1D11-437E-9333-B8C6AB39F213

Q28830846-919D1864-0C8B-4628-ADD0-FD8EDB5D6B24

Q28830846-A02533FC-4926-455E-8A0A-6E5B16ABB37E

Q28830846-A8F6C681-1A5F-43A3-96FC-721E7168C0EF

Q28830846-B38992EE-92A4-4232-BA21-D3F5F3A411D4

P2860

Q28830846-015FFF66-E348-447C-B275-B06AF363F25E

Q28830846-1913435B-71B0-495A-B62F-290F124974D6

Q28830846-21ED4B97-45FE-4A6F-9B61-36FAB6DADB44

Q28830846-519041EE-CBFA-4224-822F-04E92D602682

Q28830846-523BAD44-530C-4A46-860E-F6F1530AC8A0

Q28830846-526C15EA-EB5B-4CBB-BABB-225781004938

Q28830846-75DFF8A9-9045-4184-8B55-9708F816B865

Q28830846-8368E811-4E8C-4A89-AB5B-59148257FB14

Q28830846-85D2C1C3-A3EE-419F-BCBF-8E4B8E97F358

Q28830846-87DAAFB3-C95A-4AAC-932C-76EF6778C53F

P2888

Q28830846-C23F767E-D829-467C-8DAB-CE71D5BE14EB

P304

Q28830846-768CADD2-766B-43EF-BDF7-C014F57C7255

P31

Q28830846-C5AFDC86-94BA-445F-9BB5-67A0A99A9E3E

P3181

Q28830846-EDB4BF3B-7EB1-4891-8B85-024A93ECBE24

P356

Q28830846-C6B6D2A7-2841-442A-AB79-D7F76FC10318

P407

Q28830846-FEBABAA9-22B4-4418-8530-B53193F277DC

P478

Q28830846-DE72B63F-AF3E-4329-8A39-D399DA32192A

P50

Q28830846-5F151DBD-DE8A-47A3-80E8-5C040AF260F7

Q28830846-6BA2462A-46C6-4103-8DEC-6A5DE13F6561

P577

Q28830846-824D1EAA-EA59-4063-B945-631C2AD31630

P6179

Q28830846-99136551-4652-4A5A-91AB-1B162DA22187

P698

Q28830846-013DBE22-FB9F-4223-AE02-2310A78F346A

P932

Q28830846-6A96B832-30DC-49A4-9B85-908164459BEC

P3181

P356

P1433

Scientific Reports

P1476

Normal tissue radioprotection by amifostine via Warburg-type effects

@en

P2093

Adrian L Harris

http://www.w3.org/2001/XMLSchema#string

Alexandra Giatromanolaki

http://www.w3.org/2001/XMLSchema#string

Christopher J Schofield

http://www.w3.org/2001/XMLSchema#string

Christos E Zois

http://www.w3.org/2001/XMLSchema#string

Costantinos Simopoulos

http://www.w3.org/2001/XMLSchema#string

Dimitra Kalamida

http://www.w3.org/2001/XMLSchema#string

Efthimios Sivridis

http://www.w3.org/2001/XMLSchema#string

Ilias V Karagounis

http://www.w3.org/2001/XMLSchema#string

Michael I Koukourakis

http://www.w3.org/2001/XMLSchema#string

Stamatia Pouliliou

http://www.w3.org/2001/XMLSchema#string

P2860

Selective small molecule probes for the hypoxia inducible factor (HIF) prolyl hydroxylases

Hypoxia-inducible factor prolyl hydroxylase 2 has a high affinity for ferrous iron and 2-oxoglutarate

Why do cancers have high aerobic glycolysis?

HIF-1-mediated expression of pyruvate dehydrogenase kinase: a metabolic switch required for cellular adaptation to hypoxia

Amifostine induces anaerobic metabolism and hypoxia-inducible factor 1 alpha

Identification of compounds with binding affinity to proteins via magnetization transfer from bulk water.

Using NMR solvent water relaxation to investigate metalloenzyme-ligand binding interactions.

Radiation therapy for liver tumors: ready for inclusion in guidelines?

Reporter ligand NMR screening method for 2-oxoglutarate oxygenase inhibitors.

Amifostine in clinical oncology: current use and future applications.

P2888

P304

30986

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

4170567

http://www.w3.org/2001/XMLSchema#string

P356

10.1038/SREP30986

http://www.w3.org/2001/XMLSchema#string

P407

P478

6

http://www.w3.org/2001/XMLSchema#string

P50

Savvas P Tokmakidis

Martine I. Abboud

P577

2016-08-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1042259923

http://www.w3.org/2001/XMLSchema#string

P698

27507219

http://www.w3.org/2001/XMLSchema#string

P932

4978965

http://www.w3.org/2001/XMLSchema#string